Parma, Italy

Monica Bocchi

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Monica Bocchi: Innovator in Pharmaceutical Applications

Introduction

Monica Bocchi is a prominent inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. Her work focuses on innovative solutions that address critical health issues.

Latest Patents

One of her latest patents is for a new crystal form of glycopyrronium chloride. This innovative crystal form of threo glycopyrronium chloride is particularly useful in pharmaceutical applications. Another notable patent involves a reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C). This composition comprises a lipid carrier and a combination of polypeptide analogs that may be used for the treatment or prophylaxis of respiratory distress syndrome (RDS) and other respiratory disorders.

Career Highlights

Monica Bocchi is currently associated with Chiesi Farmaceutici S.p.A., a company known for its commitment to developing innovative pharmaceutical products. Her work at Chiesi has allowed her to focus on groundbreaking research that has the potential to improve patient outcomes.

Collaborations

Throughout her career, Monica has collaborated with notable colleagues, including Fausto Pivetti and Annamaria Soliani Raschini. These collaborations have further enriched her research and development efforts in the pharmaceutical sector.

Conclusion

Monica Bocchi's contributions to pharmaceutical innovations demonstrate her commitment to advancing healthcare solutions. Her patents reflect her dedication to improving treatments for respiratory disorders and her impact on the industry is noteworthy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…